These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Video assisted prophylactic thyroidectomy and central compartment nodes clearance in two RET gene mutation adult carriers. Miccoli P; Elisei R; Berti P; Materazzi G; Agate L; Castagna MG; Cosci B; Faviana P; Ugolini C; Pinchera A J Endocrinol Invest; 2004 Jun; 27(6):557-61. PubMed ID: 15717653 [TBL] [Abstract][Full Text] [Related]
25. Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China. Qi XP; Zhao JQ; Du ZF; Yang RR; Ma JM; Fei J; Cheng J; Han JS; Jin HY; Chen ZG; Wang JQ; Yang YP; Ying RB; Chen XL; Liu WT; Zhao Y; Jiang HL; Zhang XN Eur J Surg Oncol; 2013 Sep; 39(9):1007-12. PubMed ID: 23849459 [TBL] [Abstract][Full Text] [Related]
26. Total thyroidectomy for hereditary medullary thyroid carcinoma 12 years after correction of Hirschsprung's disease. Sasaki Y; Shimotake T; Go S; Iwai N Eur J Surg; 2001 Jun; 167(6):467-9. PubMed ID: 11471675 [No Abstract] [Full Text] [Related]
27. Normal thyroid pathology in patients undergoing thyroidectomy for finding a RETgene germline mutation: a report of three cases and review of the literature. Kebebew E; Tresler PA; Siperstein AE; Duh QY; Clark OH Thyroid; 1999 Feb; 9(2):127-31. PubMed ID: 10090311 [TBL] [Abstract][Full Text] [Related]
28. Treatment of minute medullary thyroid carcinoma in multiple endocrine neoplasia 2A families first diagnosed by DNA analysis of RET proto-oncogene mutations: a case report. Yamashita T; Lihara M; Okamoto J; Kanbe M; Ito Y; Kawakami M; Egawa S; Yamaguchi K; Obara T Jpn J Clin Oncol; 1997 Feb; 27(1):42-5. PubMed ID: 9070340 [TBL] [Abstract][Full Text] [Related]
29. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients. Niccoli-Sire P; Murat A; Rohmer V; Franc S; Chabrier G; Baldet L; Maes B; Savagner F; Giraud S; Bezieau S; Kottler ML; Morange S; Conte-Devolx B; J Clin Endocrinol Metab; 2001 Aug; 86(8):3746-53. PubMed ID: 11502806 [TBL] [Abstract][Full Text] [Related]
30. Timing and extent of surgery in patients with familial medullary thyroid carcinoma/multiple endocrine neoplasia 2A-related RET mutations not affecting codon 634. Gimm O; Ukkat J; Niederle BE; Weber T; Thanh PN; Brauckhoff M; Niederle B; Dralle H World J Surg; 2004 Dec; 28(12):1312-6. PubMed ID: 15517481 [TBL] [Abstract][Full Text] [Related]
31. [Medullary thyroid gland carcinoma. Sporadic/familial. Screening when and why?]. Frilling A; Liedke MO Internist (Berl); 1998 Jun; 39(6):588-91. PubMed ID: 9677514 [No Abstract] [Full Text] [Related]
32. Prophylactic thyroidectomy in MEN 2A syndrome: experience in a single center. Rodríguez GJ; Balsalobre MD; Pomares F; Torregrosa NM; Ríos A; Carbonell P; Glower G; Sola J; Tébar J; Parrilla P J Am Coll Surg; 2002 Aug; 195(2):159-66. PubMed ID: 12168961 [TBL] [Abstract][Full Text] [Related]
33. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations. Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097 [TBL] [Abstract][Full Text] [Related]
35. Prophylactic thyroidectomy in MEN IIA: does the calcitonin level correlate with tumor spread? Hotz HG; Runkel NS; Frank-Raue K; Raue F; Buhr HJ Langenbecks Arch Surg; 1998 Apr; 383(2):170-3. PubMed ID: 9641893 [TBL] [Abstract][Full Text] [Related]
36. RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome? Gimm O; Niederle BE; Weber T; Bockhorn M; Ukkat J; Brauckhoff M; Thanh PN; Frilling A; Klar E; Niederle B; Dralle H Surgery; 2002 Dec; 132(6):952-9; discussion 959. PubMed ID: 12490841 [TBL] [Abstract][Full Text] [Related]
37. [Prophylactic thyroidectomy in children and young people with hereditary medullary thyroid carcinoma: a Chilean experience]. Ramos C; Ojeda D; Cohn D; Wohllk N Rev Med Chil; 2005 Sep; 133(9):1029-36. PubMed ID: 16311694 [TBL] [Abstract][Full Text] [Related]
38. Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations. Pacini F; Romei C; Miccoli P; Elisei R; Molinaro E; Mancusi F; Iacconi P; Basolo F; Martino E; Pinchera A Surgery; 1995 Dec; 118(6):1031-5. PubMed ID: 7491519 [TBL] [Abstract][Full Text] [Related]
39. Recommendations for reporting C cell pathology of the thyroid. Kaserer K; Scheuba C; Neuhold N; Weinhäusel A; Vierhapper H; Niederle B Wien Klin Wochenschr; 2002 Apr; 114(7):274-8. PubMed ID: 12089863 [TBL] [Abstract][Full Text] [Related]
40. The molecular genetics of multiple endocrine neoplasia type 2A and related syndromes. Moley JF Annu Rev Med; 1997; 48():409-20. PubMed ID: 9046972 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]